Synchronized diaphragmatic stimulation: a case report of a novel extra-cardiac intervention for chronic heart failure.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
06 2022
Historique:
revised: 02 02 2022
received: 13 10 2021
accepted: 28 02 2022
pubmed: 18 3 2022
medline: 6 5 2022
entrez: 17 3 2022
Statut: ppublish

Résumé

Synchronized diaphragmatic stimulation (SDS) is a novel extra-cardiac device-based therapy for symptomatic heart failure with reduced ejection fraction. SDS provides imperceptible chronic stimulation of the diaphragm through a laparoscopically implanted system consisting of an implantable pulse generator and two sensing/stimulating leads affixed to the inferior surface of the diaphragm delivering imperceptible R-wave gaited pulses that alter intrathoracic pressure improving ventricular filling and cardiac output. We describe, in a man with a history of myocardial infarctions resulting in heart failure and persistent New York Heart Association Class III symptoms despite standard therapies, the successful implantation of SDS resulting in improved quality of life, N-terminal pro brain natriuretic peptide, cardiac function, and exercise tolerance through 12 months of follow-up. Randomized trials are now required to validate these findings.

Identifiants

pubmed: 35297198
doi: 10.1002/ehf2.13882
pmc: PMC9065831
doi:

Types de publication

Case Reports Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1677-1681

Informations de copyright

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Europace. 2009 Feb;11(2):191-9
pubmed: 19168496
ESC Heart Fail. 2022 Jun;9(3):1677-1681
pubmed: 35297198
Circulation. 2013 Oct 15;128(16):e240-327
pubmed: 23741058
JACC Heart Fail. 2019 Jul;7(7):574-585
pubmed: 31248569
J Appl Physiol (1985). 1988 Apr;64(4):1518-26
pubmed: 3378986
Pacing Clin Electrophysiol. 2007 Jun;30(6):806-7
pubmed: 17547618
J Appl Physiol (1985). 1988 Apr;64(4):1506-17
pubmed: 3378985
Chest. 1987 May;91(5):709-15
pubmed: 3552466
Eur J Heart Fail. 2014 Mar;16(3):342-9
pubmed: 24464736

Auteurs

Lee R Goldberg (LR)

Section of Advanced Heart Failure and Cardiac Transplant, Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 11-171 South Tower, Philadelphia, PA, 19104, USA.

Ana Jorbenadze (A)

Heart and Vascular Clinic, Tbilisi, Republic of Georgia.

Tamaz Shaburishvilli (T)

Heart and Vascular Clinic, Tbilisi, Republic of Georgia.

Michael J Mirro (MJ)

Indiana University and Parkview Health, Fort Wayne, IN, USA.

Marat Fudim (M)

Department of Medicine, Duke University Medical Center, Durham, NC, USA.

Michel Zuber (M)

Heart Center, Kantonsspital, Aarau, Switzerland.

Simon F Stämpfli (SF)

Heart Center, University Hospital, Zürich and Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland.

Felix C Tanner (FC)

Heart Center, University Hospital, Zürich., Switzerland.

Paul Erne (P)

Faculty of Biomedical Sciences, Universita della Svizzera Italiana, Lugano, Switzerland.

John G Cleland (JG)

Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH